Navigation Links
Certican in Medical Technology

Afinitor(R) Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma, Leading to Phase III Trial

...he prevention of organ rejection in heart and kidney transplant recipients. certican was first approved in the EU in 2003. certican is not approved for use in the US. Afinitor important safety infor...

Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib

...he prevention of organ rejection in heart and kidney transplant recipients. certican was first approved in the EU in 2003. certican is not approved for use in the US(1). For more information on Afinitor...

RAD001 Phase II Trial Results Positive in Patients with Advanced Gastric Cancer After Failure of One or More Prior Treatments

...he prevention of organ rejection in heart and kidney transplant recipients. certican was first approved in the EU in 2003. certican is not approved in the US. Disclaimer The foregoing release contai...

RAD001 Shows Potential to Reverse Resistance to Herceptin(R)* in Metastatic Breast Cancer Patients, Leading to Phase III Trial

...he prevention of organ rejection in heart and kidney transplant recipients. certican was first approved in the EU in 2003. certican is not approved in the US. In addition to breast cancer, RAD001 is ...

More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies

...ilable in different dosage strengths under the trade name Certican(R) for the prevention of organ rejection in heart and kidney transplant recipients. certican was first approved in the EU in 2003. RAD001 is being evaluated as a single agent or in combination with existing therapies for renal cell ca...

Latest RAD001 Study Results Show Further Increase in Time Without Tumor Growth in Patients With Advanced Kidney Cancer

...ilable in different dosage strengths under the trade name Certican(R) for the prevention of organ rejection in heart and kidney transplant recipients. certican was first approved in the EU in 2003. In addition to renal cell carcinoma (RCC), RAD001 is being evaluated as a single agent or in combination with ...

RAD001 Combined with Sandostatin LAR(R) Depot and as Monotherapy Controls Growth of Rare Pancreatic Neuroendocrine Tumors

...ilable in different dosage strengths under the trade name Certican(R) for the prevention of organ rejection in heart and kidney transplant recipients. certican was first approved in the European Union in 2003. RAD001 is being studied in two large Phase III studies in advanced NETs (pancreatic NET and carcin...

RAD001 Granted Priority Review in the US Based on Potential to Fill Unmet Medical Need in Patients With Advanced Kidney Cancer

...ilable in different dosage strengths under the trade name Certican(R) for the prevention of organ rejection in heart and kidney transplant recipients. certican was first approved in the EU in 2003. In addition to renal cell carcinoma (RCC), RAD001 is being evaluated as a single agent or in combination with ...

Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments

...in the world. Everolimus is approved under the trade name Certican(R) for the prevention of organ rejection in heart and kidney transplant recipients. certican was first approved in the EU in 2003 and is available in more than 60 countries. About Femara Femara(R) (letrozole tablets) is approved for the ad...

RAD001 More Than Doubles Time Without Tumor Growth After Failure of Standard Treatment in Patients With Advanced Kidney Cancer

...in the world. Everolimus is approved under the trade-name Certican(R) for the prevention of organ rejection in heart and kidney transplant recipients. certican was first approved in the EU in 2003 and is available in more than 60 countries. Disclaimer The foregoing release contains forward-looking stateme...
Other Tags
(Date:8/27/2014)... Aug. 27, 2014 (HealthDay News) -- A new genetic ... to fight the bowel disorder, researchers report. ... that affect how their genes work, and said these ... with raising the possibility of a simple diagnostic test ... the disease develops and suggest possible gene targets for ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 The ... the recipients of the 2014-2016 Basic Research Fellowships and ... career scientists, the ABTA is seeding the field with ... change our understanding of the causes, effects, diagnosis and ... by a scientific committee based on the potential to ...
(Date:8/27/2014)... According to a new market ... Market (Applications: Cardiovascular, Gynecology, Pain Management, Oncology, Urology, ... - Global Industry Analysis, Size, Share, Growth, Trends ... technologies market was valued at USD 4,698 million ... market worth USD 10,611 million in 2020 at ...
(Date:8/27/2014)... Disability (CLD) has received a two-year, $600,000 grant ... the Health Resources and Services Administration to support ... at improving services for children and youth with ... project, CLD worked with an Autism Advisory Council ... resulting plan addresses priorities of increased awareness of ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 Representatives with ... added Italy to its list of destinations for International ... for Recharge Retreats, explained that the company chose Italy ... destination for yoga teacher trainings since it's an easy ... journey for people traveling from all over Europe, UK, ...
Breaking Medicine News(10 mins):Health News:Scientists Spot Genetic Clues to Crohn's Disease 2Health News:American Brain Tumor Association Awards New Research Grants to Best and Brightest Investigators 2Health News:American Brain Tumor Association Awards New Research Grants to Best and Brightest Investigators 3Health News:Global Ablation Technologies Market Expected to Reach USD 10.6 Billion in 2020: Transparency Market Research 2Health News:Global Ablation Technologies Market Expected to Reach USD 10.6 Billion in 2020: Transparency Market Research 3Health News:Global Ablation Technologies Market Expected to Reach USD 10.6 Billion in 2020: Transparency Market Research 4Health News:Global Ablation Technologies Market Expected to Reach USD 10.6 Billion in 2020: Transparency Market Research 5Health News:Recharge Retreats Adds Italy to Its International Yoga Teacher Trainings Destinations 2Health News:Recharge Retreats Adds Italy to Its International Yoga Teacher Trainings Destinations 3
(Date:8/26/2014)... problems such as global warming and poverty the ... burden fall on our failure as consumers to ... study in the Journal of Consumer Research ... global problems from governments to consumers and ultimately ... convince politicians to encourage responsible consumption instead of ...
(Date:8/26/2014)... suggested an increased risk of autism among children ... actually reflect the known increased risk associated with ... advance online publication in Molecular Psychiatry , ... while a diagnosis of autism spectrum disorder ... prescribed antidepressants during pregnancy than in those with ...
(Date:8/26/2014)... A study from the University of Liverpool has recommended investing ... target physical inactivity and problems such as obesity in both ... papers published since 1990, the researchers found that access to ... could all motivate people to get out and take more ... of dog owners don,t take their dogs for a walk. ...
Breaking Biology News(10 mins):An inconvenient truth: Does responsible consumption benefit corporations more than society? 2Study calls into question link between prenatal antidepressant exposure and autism risk 2Study calls into question link between prenatal antidepressant exposure and autism risk 3Education and dog-friendly neighbourhoods could tackle obesity 2
Other Contents